Search - tctmd.com

Displaying 61 - 80 of 363

Sort: Relevancy | Date

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

Presenter: Joanna Chikwe

November 05, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

Pragmatic Clinical Trials: The Future is Now?

Presenter: Sreekanth Vemulapalli

November 04, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

Adapting Clinical Trials to a Black Swan Event, from Industry Perspective

Presenter: Sandeep Brar

November 04, 2021

Presentation TCT 2021

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

Presenter: Andrew Farb

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

Presentation TCT 2021

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

Presenter: Bo Xu

November 04, 2021

Presentation TCT 2021

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Presenter: William Fearon

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Presenter: Christopher Rajkumar

November 04, 2021

Presentation TCT 2021

Breaking the Small-Bore Barrier

Presenter: Amir Kaki

November 04, 2021

Presentation TCT 2021

Door to Unload: Implications for STEMI, HR-PCI and Cardiogenic Shock

Presenter: Navin Kapur

November 04, 2021

Presentation TCT 2021

Real World Evidence leading to RECOVER IV

Presenter: William O'Neill

November 04, 2021

Presentation TCT 2021

PROTECT Series leading to PROTECT IV

Presenter: Gregg Stone

November 04, 2021

Advertisement

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Pragmatic Clinical Trials: The Future is Now?

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Adapting Clinical Trials to a Black Swan Event, from Industry Perspective

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

What’s Next for Chronic Coronary Syndromes? Upcoming Clinical Trials

Breaking the Small-Bore Barrier

Door to Unload: Implications for STEMI, HR-PCI and Cardiogenic Shock

Real World Evidence leading to RECOVER IV

PROTECT Series leading to PROTECT IV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content